Related Posts
ISN Journal editorial selections on lanreotide, predicting high-risk CKD, and mitochondrial diseases
Kidney International® A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage... read more
ISN global engagement in November: supporting kidney care education in Iran, China, and Sri Lanka
This November, the ISN will contribute to nephrology events in Iran,... read more
Patient voices shaping better kidney care: the importance of earlier diagnosis
Fiona Loud A delayed kidney disease diagnosis can affect far more than... read more
Go further at WCN’27: Explore focused courses in kidney care
Keep developing your expertise with knowledge and skills you can apply... read more
Your research is published. Could it be award-winning?
Publishing original research in Kidney International® is already a significant achievement.... read more
New GREEN-K paper lays the groundwork toward more sustainable kidney care procurement practices
More than 70% of greenhouse gas emissions from kidney care come... read more
Vivekanand Jha appointed KIR editor-in-chief
Vivekanand Jha named editor-in-chief of Kidney International Reports® October 21, 2026 The International... read more
ISN Journal editorial selections on dapagliflozin, Thailand’s CKD strategy, and misleading pseudocrescents in glomerulopathy
Kidney International® New insights from DAPA-CKD indicate that dapagliflozin modulates key pathways... read more
ISN global engagement in October: supporting kidney care education in France and Bosnia and Herzegovina
This October, the ISN will contribute to nephrology events in France... read more
Explore content on novel treatments for kidney disease
Wei Chen presenting at the ISN Frontiers meeting in Dalian, China Selected... read more

